Mastiquick, 100 mg/100 mg/100 mg/10 mg, intramamarna suspenzija za krave u laktaciji
Mastiquick, 100 mg/100 mg/100 mg/10 mg, intramamarna suspenzija za krave u laktaciji
Authorised
- Benzylpenicillin procaine
- Streptomycin sulfate
- NEOMYCIN SULFATE
- Prednisolone
Product identification
Medicine name:
Mastiquick, 100 mg/100 mg/100 mg/10 mg, intramamarna suspenzija za krave u laktaciji
Active substance:
- Benzylpenicillin procaine
- Streptomycin sulfate
- NEOMYCIN SULFATE
- Prednisolone
Target species:
-
Cattle (lactating cow)
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Benzylpenicillin procaine100.00/milligram(s)1.00Syringe
-
Streptomycin sulfate100.00/milligram(s)1.00Syringe
-
NEOMYCIN SULFATE100.00/milligram(s)1.00Syringe
-
Prednisolone10.00/milligram(s)1.00Syringe
Pharmaceutical form:
-
Intramammary suspension
Withdrawal period by route of administration:
-
Intramammary use
-
Cattle (lactating cow)
-
Meat and offal7day
-
Milk96hour
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51RV01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Croatia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Dechra Regulatory B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Norbrook Laboratories Limited
- Genera d.d.
Responsible authority:
- Croatian Veterinary Institute
Authorisation number:
- UP/I-322-05/12-01/609
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Croatian (PDF)
Published on: 15/02/2022